The U.S. Food and Drug Administration (FDA) published a report entitled Nanotechnology Over a Decade of Progress and Innovation that highlights FDAs advancements in the field of nanotechnology since it released its last report in 2007. The report also reviews FDAs role in advancing the public health through its regulation of products within its jurisdiction that involve the application of nanotechnology. According to the report, FDA will rely on a combination of horizon-scanning activities to stay abreast of new developments and product applications, including by:

In addition, FDA states that its Emerging Sciences Working Group, a cross-agency, science-based forum established in 2016, continues to identify science and technology trends of relevance to FDAs regulatory responsibilities, including those for nanotechnology products. FDA notes that its science-based, product-focused regulatory framework is sufficiently flexible and robust to help ensure product safety (and effectiveness, as applicable) while supporting innovation for the development of beneficial nanotechnology products.

On August 13, 2020, FDA will hold a webinar to present the report. The webinar will include the basics of nanotechnology and will highlight the facilities, regulatory science research, guidance documents, standards, domestic and international collaborations, and emerging challenges in regulatory science. The speaker will be Anil K. Patri, Ph.D., Chair, Nanotechnology Task Force, Director, Nanocore, National Center for Toxicological Research (NCTR)/FDA.

[View source.]

Originally posted here:

FDA Publishes Report on Nanotechnology Over a Decade of Progress and Innovation, Will Hold Webinar on August 13 - JD Supra